Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 103 | 2024 | 2751 | 19.100 |
Why?
|
Atrial Appendage | 34 | 2023 | 283 | 11.270 |
Why?
|
Atrial Fibrillation | 92 | 2024 | 5127 | 11.210 |
Why?
|
Tachycardia, Ventricular | 39 | 2024 | 1304 | 8.740 |
Why?
|
Pulmonary Veins | 20 | 2024 | 743 | 5.640 |
Why?
|
Cardiac Resynchronization Therapy | 8 | 2024 | 555 | 3.760 |
Why?
|
Defibrillators, Implantable | 14 | 2024 | 1490 | 3.050 |
Why?
|
Electrophysiologic Techniques, Cardiac | 11 | 2024 | 506 | 2.470 |
Why?
|
Atrial Flutter | 6 | 2020 | 252 | 2.420 |
Why?
|
Pacemaker, Artificial | 7 | 2024 | 807 | 2.260 |
Why?
|
Anticoagulants | 27 | 2024 | 4812 | 2.200 |
Why?
|
Pericardium | 9 | 2024 | 675 | 1.980 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 4 | 2020 | 162 | 1.760 |
Why?
|
Thromboembolism | 9 | 2021 | 995 | 1.720 |
Why?
|
Electrocardiography | 21 | 2024 | 6377 | 1.720 |
Why?
|
Cardiomyopathies | 15 | 2024 | 1964 | 1.640 |
Why?
|
Heart Conduction System | 10 | 2024 | 1007 | 1.620 |
Why?
|
Body Surface Potential Mapping | 3 | 2019 | 228 | 1.620 |
Why?
|
Arrhythmias, Cardiac | 11 | 2023 | 2244 | 1.510 |
Why?
|
Anti-Arrhythmia Agents | 11 | 2022 | 774 | 1.480 |
Why?
|
Ventricular Septum | 2 | 2022 | 76 | 1.450 |
Why?
|
Epicardial Mapping | 9 | 2024 | 58 | 1.420 |
Why?
|
Triose-Phosphate Isomerase | 2 | 2020 | 45 | 1.330 |
Why?
|
Recurrence | 26 | 2024 | 8466 | 1.290 |
Why?
|
Treatment Outcome | 70 | 2024 | 64684 | 1.260 |
Why?
|
Action Potentials | 11 | 2024 | 1834 | 1.260 |
Why?
|
Cryosurgery | 4 | 2023 | 474 | 1.240 |
Why?
|
Death, Sudden, Cardiac | 5 | 2024 | 1555 | 1.240 |
Why?
|
Bundle-Branch Block | 3 | 2024 | 276 | 1.200 |
Why?
|
Myocarditis | 3 | 2024 | 788 | 1.120 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 2 | 2018 | 148 | 1.120 |
Why?
|
Heart Ventricles | 13 | 2023 | 3807 | 1.110 |
Why?
|
Surgery, Computer-Assisted | 3 | 2020 | 1007 | 1.080 |
Why?
|
Heart Rate | 13 | 2024 | 4195 | 1.060 |
Why?
|
Heart Failure | 9 | 2024 | 11670 | 1.040 |
Why?
|
Heart Diseases | 6 | 2023 | 2781 | 1.020 |
Why?
|
Anesthesia, Local | 3 | 2024 | 277 | 1.000 |
Why?
|
Ventricular Premature Complexes | 4 | 2020 | 112 | 0.990 |
Why?
|
Humans | 196 | 2024 | 761572 | 0.970 |
Why?
|
Echocardiography, Transesophageal | 10 | 2023 | 1086 | 0.970 |
Why?
|
Cardiac Surgical Procedures | 7 | 2023 | 3627 | 0.950 |
Why?
|
Septal Occluder Device | 3 | 2020 | 125 | 0.920 |
Why?
|
Heart Injuries | 2 | 2023 | 206 | 0.890 |
Why?
|
Femoral Vein | 1 | 2024 | 153 | 0.890 |
Why?
|
Endocardium | 6 | 2024 | 248 | 0.870 |
Why?
|
Fluoroscopy | 5 | 2024 | 947 | 0.860 |
Why?
|
Stroke | 19 | 2024 | 9758 | 0.790 |
Why?
|
Autonomic Denervation | 1 | 2021 | 4 | 0.760 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2024 | 285 | 0.750 |
Why?
|
Ventricular Function, Left | 9 | 2023 | 3879 | 0.750 |
Why?
|
Stroke Volume | 12 | 2024 | 5496 | 0.750 |
Why?
|
Microbubbles | 2 | 2022 | 135 | 0.750 |
Why?
|
Heart Atria | 9 | 2023 | 1345 | 0.730 |
Why?
|
Hemorrhage | 12 | 2024 | 3424 | 0.730 |
Why?
|
Cause of Death | 3 | 2024 | 3683 | 0.730 |
Why?
|
Microvessels | 2 | 2015 | 577 | 0.720 |
Why?
|
Chagas Cardiomyopathy | 1 | 2021 | 71 | 0.710 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2020 | 32 | 0.710 |
Why?
|
Prospective Studies | 35 | 2024 | 54426 | 0.710 |
Why?
|
Thrombosis | 6 | 2020 | 2942 | 0.700 |
Why?
|
Vitamin K | 2 | 2019 | 318 | 0.700 |
Why?
|
Patient Positioning | 1 | 2023 | 326 | 0.700 |
Why?
|
Accessory Atrioventricular Bundle | 1 | 2020 | 58 | 0.700 |
Why?
|
Postoperative Complications | 10 | 2020 | 15633 | 0.690 |
Why?
|
Phrenic Nerve | 1 | 2019 | 79 | 0.670 |
Why?
|
Aged | 66 | 2024 | 169310 | 0.660 |
Why?
|
Coronary Vessels | 4 | 2019 | 3096 | 0.660 |
Why?
|
Anemia, Hemolytic, Congenital Nonspherocytic | 1 | 2020 | 55 | 0.650 |
Why?
|
Cardiac Imaging Techniques | 3 | 2019 | 267 | 0.650 |
Why?
|
Myocardial Stunning | 3 | 2014 | 66 | 0.640 |
Why?
|
Ventricular Function | 1 | 2020 | 406 | 0.630 |
Why?
|
Ablation Techniques | 3 | 2018 | 248 | 0.630 |
Why?
|
Myocardial Ischemia | 5 | 2021 | 2113 | 0.620 |
Why?
|
Middle Aged | 70 | 2024 | 220920 | 0.620 |
Why?
|
Nitroso Compounds | 1 | 2018 | 71 | 0.610 |
Why?
|
Prosthesis-Related Infections | 1 | 2023 | 487 | 0.600 |
Why?
|
Sheep Diseases | 2 | 2014 | 18 | 0.590 |
Why?
|
Male | 89 | 2024 | 360842 | 0.590 |
Why?
|
Lidocaine | 1 | 2021 | 538 | 0.590 |
Why?
|
Warfarin | 4 | 2018 | 1483 | 0.580 |
Why?
|
Echocardiography | 5 | 2024 | 4989 | 0.570 |
Why?
|
Intracranial Hemorrhages | 2 | 2019 | 822 | 0.550 |
Why?
|
Atrioventricular Node | 1 | 2017 | 180 | 0.550 |
Why?
|
Magnetic Resonance Imaging, Cine | 4 | 2018 | 1050 | 0.540 |
Why?
|
Female | 84 | 2024 | 392686 | 0.510 |
Why?
|
Surgical Fixation Devices | 1 | 2015 | 8 | 0.510 |
Why?
|
Electric Countershock | 1 | 2018 | 533 | 0.500 |
Why?
|
Paramphistomatidae | 1 | 2014 | 1 | 0.490 |
Why?
|
Oxyclozanide | 1 | 2014 | 2 | 0.490 |
Why?
|
Trematode Infections | 1 | 2014 | 3 | 0.490 |
Why?
|
Administration, Oral | 9 | 2021 | 4021 | 0.490 |
Why?
|
Anthelmintics | 2 | 2014 | 83 | 0.480 |
Why?
|
Torsades de Pointes | 1 | 2015 | 78 | 0.480 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 415 | 0.480 |
Why?
|
Myocardium | 4 | 2024 | 4725 | 0.470 |
Why?
|
Tomography, X-Ray Computed | 11 | 2024 | 20571 | 0.470 |
Why?
|
Risk Assessment | 21 | 2024 | 23996 | 0.470 |
Why?
|
Feasibility Studies | 3 | 2024 | 5247 | 0.470 |
Why?
|
Time Factors | 23 | 2024 | 39970 | 0.460 |
Why?
|
Primary Prevention | 2 | 2018 | 1186 | 0.450 |
Why?
|
Randomized Controlled Trials as Topic | 16 | 2024 | 10212 | 0.440 |
Why?
|
Cerebral Infarction | 1 | 2018 | 983 | 0.440 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2013 | 65 | 0.440 |
Why?
|
Myocardial Infarction | 5 | 2021 | 11461 | 0.440 |
Why?
|
Medically Underserved Area | 1 | 2015 | 254 | 0.440 |
Why?
|
Amiodarone | 3 | 2021 | 217 | 0.430 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2015 | 187 | 0.430 |
Why?
|
Methadone | 1 | 2015 | 321 | 0.430 |
Why?
|
Bundle of His | 3 | 2023 | 101 | 0.420 |
Why?
|
Bathing Beaches | 1 | 2022 | 12 | 0.410 |
Why?
|
Radiographic Image Enhancement | 2 | 2017 | 876 | 0.410 |
Why?
|
Ulcer | 1 | 2013 | 204 | 0.390 |
Why?
|
New York City | 4 | 2020 | 731 | 0.390 |
Why?
|
Ventricular Remodeling | 2 | 2017 | 1267 | 0.380 |
Why?
|
Acidosis | 1 | 2013 | 268 | 0.380 |
Why?
|
Therapeutic Irrigation | 3 | 2023 | 292 | 0.380 |
Why?
|
Long QT Syndrome | 1 | 2015 | 467 | 0.370 |
Why?
|
Mutation, Missense | 1 | 2020 | 2571 | 0.370 |
Why?
|
Predictive Value of Tests | 12 | 2024 | 15266 | 0.360 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 36429 | 0.350 |
Why?
|
Hemodynamics | 2 | 2017 | 4160 | 0.340 |
Why?
|
Risk Factors | 29 | 2024 | 74213 | 0.330 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2017 | 1553 | 0.330 |
Why?
|
Pain | 2 | 2022 | 5073 | 0.330 |
Why?
|
Coronary Sinus | 2 | 2020 | 84 | 0.320 |
Why?
|
Ethanol | 1 | 2015 | 1324 | 0.310 |
Why?
|
Coronary Angiography | 3 | 2015 | 4471 | 0.310 |
Why?
|
Atrial Function, Left | 3 | 2022 | 185 | 0.310 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1462 | 0.310 |
Why?
|
Artifacts | 1 | 2017 | 1911 | 0.310 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2024 | 866 | 0.310 |
Why?
|
Ecosystem | 1 | 2022 | 490 | 0.300 |
Why?
|
Echocardiography, Stress | 3 | 2015 | 134 | 0.300 |
Why?
|
Chest Pain | 1 | 2015 | 1091 | 0.290 |
Why?
|
Urban Population | 1 | 2015 | 2036 | 0.290 |
Why?
|
Follow-Up Studies | 17 | 2024 | 39107 | 0.290 |
Why?
|
Aortic Diseases | 1 | 2013 | 735 | 0.280 |
Why?
|
Aortic Valve | 1 | 2017 | 1955 | 0.280 |
Why?
|
Heart-Assist Devices | 1 | 2017 | 1287 | 0.270 |
Why?
|
Registries | 7 | 2024 | 8224 | 0.270 |
Why?
|
Retrospective Studies | 22 | 2024 | 80646 | 0.260 |
Why?
|
Antithrombins | 2 | 2018 | 294 | 0.260 |
Why?
|
Tricuspid Valve | 2 | 2018 | 410 | 0.240 |
Why?
|
Diagnostic Imaging | 2 | 2019 | 3530 | 0.240 |
Why?
|
Prognosis | 13 | 2018 | 29629 | 0.240 |
Why?
|
Defibrillators | 1 | 2024 | 39 | 0.230 |
Why?
|
Hospitalization | 6 | 2024 | 10721 | 0.230 |
Why?
|
Calcium Channel Blockers | 3 | 2012 | 694 | 0.230 |
Why?
|
Severity of Illness Index | 7 | 2018 | 15843 | 0.220 |
Why?
|
Aged, 80 and over | 13 | 2024 | 58986 | 0.220 |
Why?
|
Heart | 3 | 2023 | 4404 | 0.220 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2024 | 2118 | 0.210 |
Why?
|
Databases, Factual | 4 | 2024 | 7967 | 0.210 |
Why?
|
Sensitivity and Specificity | 6 | 2017 | 14666 | 0.210 |
Why?
|
Survival Rate | 6 | 2024 | 12725 | 0.210 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2022 | 65 | 0.200 |
Why?
|
Prone Position | 1 | 2023 | 196 | 0.200 |
Why?
|
Aortic Valve Stenosis | 1 | 2014 | 2001 | 0.200 |
Why?
|
Dobutamine | 2 | 2012 | 116 | 0.190 |
Why?
|
Acute Coronary Syndrome | 1 | 2014 | 2190 | 0.190 |
Why?
|
Apnea | 1 | 2023 | 195 | 0.190 |
Why?
|
Cardiac Electrophysiology | 1 | 2021 | 59 | 0.190 |
Why?
|
Esophageal Fistula | 1 | 2021 | 60 | 0.190 |
Why?
|
Tidal Volume | 1 | 2023 | 488 | 0.180 |
Why?
|
Syncope, Vasovagal | 1 | 2020 | 38 | 0.170 |
Why?
|
Sarcoidosis | 2 | 2023 | 521 | 0.170 |
Why?
|
Tachycardia, Supraventricular | 1 | 2022 | 273 | 0.170 |
Why?
|
Incidence | 9 | 2020 | 21355 | 0.170 |
Why?
|
Hydrogen Bonding | 1 | 2020 | 291 | 0.170 |
Why?
|
Causality | 2 | 2017 | 1242 | 0.170 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2020 | 116 | 0.170 |
Why?
|
Pericarditis | 1 | 2021 | 135 | 0.170 |
Why?
|
Contrast Media | 6 | 2020 | 5311 | 0.160 |
Why?
|
Vena Cava, Superior | 1 | 2020 | 195 | 0.160 |
Why?
|
Renin | 2 | 2012 | 641 | 0.160 |
Why?
|
Photoperiod | 1 | 2020 | 139 | 0.160 |
Why?
|
Insufflation | 1 | 2019 | 62 | 0.160 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 398 | 0.160 |
Why?
|
Cardiotonic Agents | 2 | 2012 | 539 | 0.160 |
Why?
|
Review Literature as Topic | 1 | 2021 | 348 | 0.160 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2017 | 1725 | 0.150 |
Why?
|
Chagas Disease | 1 | 2020 | 167 | 0.150 |
Why?
|
Workflow | 1 | 2023 | 851 | 0.150 |
Why?
|
Antihypertensive Agents | 3 | 2013 | 2024 | 0.150 |
Why?
|
Reproducibility of Results | 4 | 2017 | 20099 | 0.150 |
Why?
|
Hirudins | 1 | 2018 | 179 | 0.150 |
Why?
|
Cardiac Output, Low | 1 | 2018 | 191 | 0.150 |
Why?
|
Coronary Disease | 1 | 2012 | 5914 | 0.140 |
Why?
|
Coronary Artery Disease | 2 | 2014 | 6403 | 0.140 |
Why?
|
Atherosclerosis | 1 | 2013 | 3408 | 0.140 |
Why?
|
Comorbidity | 3 | 2017 | 10508 | 0.140 |
Why?
|
Troponin | 1 | 2020 | 502 | 0.140 |
Why?
|
Edema | 2 | 2011 | 766 | 0.140 |
Why?
|
Myocardial Contraction | 2 | 2012 | 1515 | 0.140 |
Why?
|
Vascular System Injuries | 1 | 2019 | 246 | 0.130 |
Why?
|
New York | 2 | 2018 | 874 | 0.130 |
Why?
|
Uruguay | 2 | 2022 | 104 | 0.130 |
Why?
|
Cicatrix | 2 | 2019 | 798 | 0.130 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2017 | 123 | 0.130 |
Why?
|
Punctures | 1 | 2017 | 366 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2013 | 1039 | 0.130 |
Why?
|
Anesthesia, General | 1 | 2022 | 1174 | 0.130 |
Why?
|
Syncope | 1 | 2018 | 427 | 0.130 |
Why?
|
Crystallography, X-Ray | 1 | 2020 | 1990 | 0.130 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2024 | 1068 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2018 | 6815 | 0.120 |
Why?
|
Abomasum | 1 | 2014 | 2 | 0.120 |
Why?
|
Patient Admission | 2 | 2020 | 1367 | 0.120 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 343 | 0.120 |
Why?
|
Emergency Service, Hospital | 1 | 2015 | 7879 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9280 | 0.120 |
Why?
|
Pericardial Effusion | 1 | 2017 | 247 | 0.120 |
Why?
|
Hypertension | 5 | 2018 | 8540 | 0.120 |
Why?
|
Sheep | 2 | 2014 | 1440 | 0.120 |
Why?
|
Goals | 1 | 2020 | 711 | 0.120 |
Why?
|
Gastrointestinal Contents | 1 | 2014 | 42 | 0.120 |
Why?
|
Sexually Transmitted Diseases | 1 | 2020 | 662 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2018 | 617 | 0.120 |
Why?
|
Sex Factors | 3 | 2024 | 10553 | 0.120 |
Why?
|
Thinness | 1 | 2018 | 490 | 0.120 |
Why?
|
Heparin | 2 | 2018 | 1634 | 0.120 |
Why?
|
Anesthetics, Local | 1 | 2021 | 997 | 0.110 |
Why?
|
Prevalence | 4 | 2020 | 15732 | 0.110 |
Why?
|
Needles | 1 | 2017 | 451 | 0.110 |
Why?
|
Inpatients | 3 | 2020 | 2548 | 0.110 |
Why?
|
Ventricular Function, Right | 1 | 2017 | 617 | 0.110 |
Why?
|
Fascioliasis | 1 | 2012 | 14 | 0.110 |
Why?
|
Ischemic Attack, Transient | 1 | 2019 | 882 | 0.110 |
Why?
|
Heroin | 1 | 2014 | 119 | 0.110 |
Why?
|
Fasciola hepatica | 1 | 2012 | 15 | 0.110 |
Why?
|
Equipment Failure Analysis | 1 | 2015 | 847 | 0.110 |
Why?
|
Heroin Dependence | 1 | 2014 | 172 | 0.110 |
Why?
|
Equipment Design | 2 | 2024 | 3511 | 0.110 |
Why?
|
Albendazole | 1 | 2012 | 50 | 0.100 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2630 | 0.100 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2013 | 244 | 0.100 |
Why?
|
Propensity Score | 1 | 2020 | 1913 | 0.100 |
Why?
|
HIV-1 | 2 | 2020 | 6863 | 0.100 |
Why?
|
Prion Diseases | 1 | 2014 | 100 | 0.100 |
Why?
|
Protein Conformation | 1 | 2020 | 3968 | 0.100 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2014 | 281 | 0.100 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2013 | 139 | 0.100 |
Why?
|
Tissue Survival | 1 | 2012 | 119 | 0.100 |
Why?
|
Radiation Protection | 1 | 2015 | 424 | 0.100 |
Why?
|
Treatment Failure | 1 | 2018 | 2644 | 0.100 |
Why?
|
Narcotics | 1 | 2014 | 336 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1241 | 0.100 |
Why?
|
Angiotensins | 1 | 2012 | 143 | 0.100 |
Why?
|
ROC Curve | 3 | 2017 | 3579 | 0.100 |
Why?
|
Foramen Ovale, Patent | 1 | 2014 | 208 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2413 | 0.090 |
Why?
|
Peritoneal Dialysis | 1 | 2012 | 159 | 0.090 |
Why?
|
Latin America | 2 | 2023 | 410 | 0.090 |
Why?
|
Ventricular Fibrillation | 2 | 2024 | 537 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2192 | 0.090 |
Why?
|
Hydrochlorothiazide | 1 | 2011 | 94 | 0.090 |
Why?
|
Temperature | 1 | 2017 | 2226 | 0.090 |
Why?
|
Pain Measurement | 1 | 2021 | 3551 | 0.090 |
Why?
|
Sex Distribution | 1 | 2015 | 2281 | 0.090 |
Why?
|
Angioedema | 1 | 2012 | 184 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4853 | 0.090 |
Why?
|
Echocardiography, Doppler | 1 | 2014 | 897 | 0.090 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2013 | 370 | 0.090 |
Why?
|
Adult | 16 | 2024 | 221203 | 0.090 |
Why?
|
Prosthesis Design | 1 | 2017 | 2115 | 0.090 |
Why?
|
Intraoperative Complications | 1 | 2017 | 1166 | 0.090 |
Why?
|
Models, Molecular | 1 | 2020 | 5439 | 0.090 |
Why?
|
Anemia | 1 | 2019 | 1509 | 0.090 |
Why?
|
Peritonitis | 1 | 2012 | 368 | 0.090 |
Why?
|
Patient Discharge | 1 | 2023 | 3443 | 0.090 |
Why?
|
HIV Infections | 4 | 2020 | 17352 | 0.090 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2023 | 1875 | 0.090 |
Why?
|
Age Distribution | 1 | 2015 | 2880 | 0.080 |
Why?
|
Renin-Angiotensin System | 2 | 2012 | 737 | 0.080 |
Why?
|
Biodiversity | 1 | 2022 | 347 | 0.080 |
Why?
|
Lung Diseases | 1 | 2019 | 1909 | 0.080 |
Why?
|
Acetaminophen | 1 | 2013 | 554 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2018 | 2135 | 0.080 |
Why?
|
Electric Impedance | 2 | 2024 | 757 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1866 | 0.080 |
Why?
|
Circadian Rhythm | 1 | 2020 | 2576 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4176 | 0.080 |
Why?
|
Burns | 1 | 2019 | 1882 | 0.080 |
Why?
|
Population Surveillance | 1 | 2018 | 2598 | 0.070 |
Why?
|
Canada | 2 | 2023 | 2122 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2012 | 858 | 0.070 |
Why?
|
United States | 7 | 2020 | 72335 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2018 | 1273 | 0.070 |
Why?
|
Safety | 1 | 2012 | 1150 | 0.070 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1474 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1096 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1277 | 0.070 |
Why?
|
Survival Analysis | 2 | 2017 | 10090 | 0.070 |
Why?
|
Drug Resistance | 1 | 2012 | 1596 | 0.070 |
Why?
|
Patient Care | 1 | 2012 | 622 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2018 | 5112 | 0.070 |
Why?
|
Kidney | 1 | 2021 | 7047 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2243 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18398 | 0.060 |
Why?
|
Exercise Test | 1 | 2013 | 2127 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8633 | 0.060 |
Why?
|
Chi-Square Distribution | 3 | 2018 | 3416 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2018 | 3600 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2018 | 3049 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2018 | 2183 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18253 | 0.060 |
Why?
|
Purkinje Fibers | 1 | 2024 | 31 | 0.060 |
Why?
|
Cell Survival | 1 | 2014 | 5791 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1516 | 0.060 |
Why?
|
Gadolinium | 2 | 2020 | 960 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2188 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2018 | 12463 | 0.060 |
Why?
|
Program Evaluation | 1 | 2012 | 2495 | 0.060 |
Why?
|
Fibrinolytic Agents | 2 | 2024 | 2084 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12975 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2319 | 0.050 |
Why?
|
Chlorhexidine | 1 | 2023 | 160 | 0.050 |
Why?
|
Asia | 1 | 2023 | 619 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 2013 | 1924 | 0.050 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1578 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7391 | 0.050 |
Why?
|
Animals | 6 | 2024 | 168467 | 0.040 |
Why?
|
Tachycardia | 1 | 2022 | 600 | 0.040 |
Why?
|
Tilt-Table Test | 1 | 2020 | 79 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3688 | 0.040 |
Why?
|
Off-Label Use | 1 | 2021 | 185 | 0.040 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 6312 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2024 | 592 | 0.040 |
Why?
|
Medicare | 1 | 2017 | 6770 | 0.040 |
Why?
|
Dogs | 1 | 2024 | 3839 | 0.040 |
Why?
|
Catheters | 1 | 2022 | 427 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 551 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13367 | 0.040 |
Why?
|
Logistic Models | 1 | 2012 | 13255 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9319 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2017 | 320 | 0.030 |
Why?
|
Prednisone | 1 | 2021 | 1563 | 0.030 |
Why?
|
Device Removal | 1 | 2021 | 630 | 0.030 |
Why?
|
Young Adult | 3 | 2020 | 59255 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8002 | 0.030 |
Why?
|
Sleep | 2 | 2023 | 4768 | 0.030 |
Why?
|
Sexual Partners | 1 | 2020 | 796 | 0.030 |
Why?
|
Blood Pressure | 3 | 2018 | 8481 | 0.030 |
Why?
|
Odds Ratio | 2 | 2018 | 9646 | 0.030 |
Why?
|
Risk-Taking | 1 | 2020 | 1038 | 0.030 |
Why?
|
Methotrexate | 1 | 2021 | 1719 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6484 | 0.030 |
Why?
|
Patient Compliance | 1 | 2024 | 2690 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10766 | 0.030 |
Why?
|
Drug Interactions | 1 | 2017 | 1416 | 0.030 |
Why?
|
Dihydropyridines | 1 | 2012 | 67 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2811 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2020 | 1334 | 0.020 |
Why?
|
Argentina | 1 | 2012 | 246 | 0.020 |
Why?
|
Cohort Studies | 3 | 2020 | 41493 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 651 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3332 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2020 | 2180 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2017 | 942 | 0.020 |
Why?
|
Body Mass Index | 2 | 2018 | 12954 | 0.020 |
Why?
|
Fumarates | 1 | 2011 | 131 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3769 | 0.020 |
Why?
|
Oligodendroglia | 1 | 2014 | 538 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3133 | 0.020 |
Why?
|
Brain Edema | 1 | 2014 | 604 | 0.020 |
Why?
|
Heart Arrest | 1 | 2019 | 1514 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2017 | 6228 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6534 | 0.020 |
Why?
|
Child | 1 | 2017 | 80156 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 88324 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 2012 | 539 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1638 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4431 | 0.020 |
Why?
|
Amides | 1 | 2011 | 449 | 0.020 |
Why?
|
Treatment Refusal | 1 | 2011 | 429 | 0.020 |
Why?
|
Swine | 1 | 2017 | 5915 | 0.020 |
Why?
|
Placebos | 1 | 2011 | 1667 | 0.020 |
Why?
|
Morbidity | 1 | 2012 | 1750 | 0.020 |
Why?
|
Overweight | 1 | 2018 | 2417 | 0.020 |
Why?
|
Fluorocarbons | 1 | 2012 | 492 | 0.020 |
Why?
|
Astrocytes | 1 | 2014 | 1346 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4244 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2017 | 1852 | 0.020 |
Why?
|
Mortality | 1 | 2016 | 2901 | 0.020 |
Why?
|
Educational Status | 1 | 2012 | 2522 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4527 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2018 | 5293 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7407 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9326 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8830 | 0.010 |
Why?
|
Patient Readmission | 1 | 2017 | 3271 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2016 | 3233 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6344 | 0.010 |
Why?
|
Recovery of Function | 1 | 2011 | 2979 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3358 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13510 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 12947 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6180 | 0.010 |
Why?
|
Brain | 1 | 2014 | 27120 | 0.000 |
Why?
|